Antibody-targeted imaging of gastric cancer Review


Authors: Mandleywala, K.; Shmuel, S.; Pereira, P. M. R.; Lewis, J. S.
Review Title: Antibody-targeted imaging of gastric cancer
Abstract: The specificity of antibodies for antigens overexpressed or uniquely expressed in tumor cells makes them ideal candidates in the development of bioconjugates for tumor imaging. Molecular imaging can aid clinicians in the diagnosis of gastric tumors and in selecting patients for therapies targeting receptors with a heterogeneous intratumoral or intertumoral expression. Antibodies labeled with an imaging radiometal can be used to detect primary tumors and metastases using whole-body positron emission tomography (PET) or single photon emission computed tomography (SPECT), both during diagnosis and monitoring disease response. Conjugated with fluorescent dyes, antibodies can image tumors by targeted optical imaging. This review provides an overview of the most recent advances in the use of antibodies labeled with radiometals or conjugated with fluorescent dyes for gastric cancer imaging. © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Keywords: molecular imaging; pet; gastric cancer; spect; optical imaging
Journal Title: Molecules
Volume: 25
Issue: 20
ISSN: 1420-3049
Publisher: MDPI  
Date Published: 2020-10-01
Start Page: 4621
Language: English
DOI: 10.3390/molecules25204621
PUBMED: 33050602
PROVIDER: scopus
PMCID: PMC7587187
DOI/URL:
Notes: Review -- Export Date: 2 November 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jason S Lewis
    460 Lewis
  2. Shayla S Shmuel
    2 Shmuel